THE BASIC PRINCIPLES OF SYMPTOMS

Pick other brokers are advisable as choice brokers based on administration challenges and/or adverse impact profile.  Zidovudine combined with lamivudine is the choice NRTI backbone but is linked to more hematologic toxicity. Lopinavir/ritonavir is an alternative PI agent with proven safety but reveals increased gastrointestinal intolerance.Editor